Neuren Pharmaceuticals | NEU - Debt

Stock Price
12.52
Daily Change
-0.68 -5.15%
Monthly
-31.51%
Yearly
-10.70%
Q1 Forecast
16.35

Neuren Pharmaceuticals reported AUD0 in Debt for its fiscal semester ending in December of 2024.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 44.59M 1.4M Jun/2025
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Genetic Signatures AUD 791K 223K Jun/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
Medical Developments International AUD 1.99M 152K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organon & Co USD 8.83B 68M Sep/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Starpharma Holdings AUD 2.4M 73K Jun/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Telix Pharmaceuticals AUD 581.45M 559.3M Dec/2024
Viatris USD 14.44B 318.8M Sep/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025